USPTO serial 79406379
ELEKTA EVO
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- LAVOIE, RYAN CHRISTOPHER
- Law office
- TMEG LAW OFFICE 108
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with ELEKTA EVO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Stephanie H. Bald
Stephanie H. Bald Kelly IP, LLP1150 Connecticut Avenue NW, Suite 600Washington, DC 20036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Recorded and downloadable computer software for use with medical treatment, namely for planning or simulation of medical treatment, namely, for use in oncology and radiotherapy; recorded and downloadable computer software for handling, displaying, transmitting and transfer of patient data, information and medical images; recorded and downloadable computer software for the generation, capture, analysis and display of medical images including X-rays, magnetic resonance images (MR), computed tomography images (CT), cone beam computed tomography (CBCT) images, ultrasound images, positron emission tomography images, single-photon emission computed tomography images (SPECT); recorded and downloadable computer software for the calculation of dose planning and flow charts and for display during radiotherapy; recorded and downloadable computer software for managing medical systems and devices; recorded and downloadable software for processing images; recorded and downloadable data analytics software for oncology and radiotherapy equipment and linear accelerators for use in oncology and radiotherapy; recorded and downloadable linear accelerator management and control software; recorded and downloadable computer software for medical database management for use in oncology and radiotherapy; recorded and downloadable treatment planning and workflow software; recorded and downloadable software for cloud based services, data analytics and informatics for use with oncology and radiotherapy equipment and linear accelerators for use in oncology and radiotherapy, namely, for storing and managing electronic data, editing digital photos, sharing and uploading data; recorded and downloadable software for remote access allowing wireless connectivity for use in oncology and radiotherapy equipment and linear accelerators for use in radiotherapy; recorded and downloadable software for measuring and analyzing radiation dose delivery in radiosurgery and radiotherapy equipment; recorded and downloadable quality assurance software for oncology and radiotherapy equipment; recorded and downloadable calibration software for use in calibrating oncology and radiotherapy equipment and linear accelerators for use in oncology and radiotherapy; recorded and downloadable software and computerized systems for management of clinical information and patient data, treatment delivery, patient record archiving and clinical charting; data and databases all recorded electronically, magnetically and optically recorded on computer media and pre-recorded optical discs in the field of oncology and radiotherapy equipment and linear accelerators for use in oncology and radiotherapy; downloadable user, training and instruction manuals for oncology and radiation therapy medical equipment and software used in connection therewith; downloadable electronic magazines in the field of oncology and radiation therapy; downloadable remote software applications for planning, simulating and administering radiotherapy treatments in the fields of oncology and central nervous system disorders; computer hardware and recorded and downloadable software for quality assurance and calibration measurements in medical and surgical equipment; optical receivers; optical transmitters | ACTIVE | — |
| 010 | Medical and surgical apparatus and instruments, namely, oncology and radiotherapy equipment and linear accelerators; apparatus and instruments for use with medical analysis for identification, planning as well as implementing of treatment against cancer, benign diseases or neurological disorders using radiation; radiosurgery and radiotherapy equipment, apparatus and instruments, namely linear accelerators, oncology and radiation treatment planning systems, and patient positioning and immobilization devices for radiotherapy; image guided radiation therapy device for use in medicine and downloadable and recorded computer software and hardware sold as a unit therewith; testing apparatus for medical purposes, namely, medical diagnostic apparatus for tissue-based diagnostic testing, cytology, and cell-based testing in the field of oncology; radiological apparatus for medical purposes; collimators for medical purposes; fasteners adapted for the restraining of limbs during measurement and treatment, namely stretcher straps; medical and radiographic linear accelerators; radiation beam collimation apparatus for radiotherapy; magnetoencephalography medical imaging equipment; radiographic and X-ray medical apparatus; X-ray tubes for medical purposes; X-ray medical imaging tubes for radiation; radiation delivery devices, for medical purposes; X-ray image intensifiers, for medical purposes; accelerators for charged particles for therapeutic purposes; medical imaging apparatus for the creation or transmission of images, video or data relating to a medical treatment for diagnostic or clinical use; surgical tables, beds and armchairs, treatment, medical-care and operating tables, beds and armchairs; furniture especially made for medical purposes; medical instruments, equipment and apparatus, namely, oncology and radiotherapy apparatus for the manipulation and positioning of patients in situ for radiotherapy; patient safety restraints; imaging and treatment simulation apparatus for treatment planning and simulation, in the nature of medical diagnostic and treatment apparatus for detecting and treating cancer, not being teaching aids; medical imaging apparatus; X-ray radiographic and fluoroscopic imaging systems for medical purposes; replacement parts therefor | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 23, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 23, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 23, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 15, 2026 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jun 9, 2026 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| May 19, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 28, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 28, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 28, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 28, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 28, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Apr 28, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 28, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 28, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 28, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 19, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 19, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 19, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 26, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 9, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 9, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 29, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 29, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 29, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 4, 2025 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Aug 26, 2025 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jul 28, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 28, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 28, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 28, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 28, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 7, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 7, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 7, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 10, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 10, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 10, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 21, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 29, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 10, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 10, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 26, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 25, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 20, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 11, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 11, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 10, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |